In the future, thanks to Johns Hopkins researchers, doctors seeking to crush cancer may wield minuscule molecular nanoSABERs that allow them to look at tumors in ways never before possible. The ability to visualize tumors in their entirety—and early—could significantly enhance cancer imaging, inform treatment options, and improve patient outcomes. Ishan Barman Associate professor, Whiting School "This could be a game changer for cancer treatment." The Johns Hopkins team's approach could solve that problem, allowing clinicians to visualize cancerous activity across entire tumors, providing insights into their possible aggressiveness. Study co-authors at Johns Hopkins include Behnaz Ghaemi, Piyush Raj, Aruna Singh, Lintong Wu, Dian R. Arifin, and Michael T. McMahon.